Apimeds Pharmaceuticals US Inc. (APUS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Apimeds Pharmaceuticals US Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$3.07
+0.66% today
Market cap
$5M
Overall quality
58/100
Kronos AI 30-day
+66.0%
8 of 8 simulated paths end higher
Apimeds Pharmaceuticals US Inc. (APUS) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $5M. It trades at $3.07, up 0.66% today. Its overall quality score is 58 out of 100, ranked against the whole US market. Kronos AI's 30-day forecast is +66.0% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $5.06 (+66.0%) |
| Likely range | +19.1% … +90.4% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 50 |
| Solvency | 80 |
| Growth | 44 |
| Overall | 58 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.